Targeted Disruption of Fibrinogen Like Protein-1 Accelerates Hepatocellular Carcinoma Development

Biochemical and Biophysical Research Communications - United States
doi 10.1016/j.bbrc.2015.07.078
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Programmed Cell Death Protein-1-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Targeted Therapy in Hepatocellular Carcinoma

International Journal of Hepatology
Hepatology
2011English

Molecular Targeted Therapy of Hepatocellular Carcinoma

Journal of Cancer Therapy
2013English

Fibrinogen-Like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

Cell
BiochemistryGeneticsMolecular Biology
2019English

Liver Regeneration Accelerates Hepatitis B Virus-Related Tumorigenesis of Hepatocellular Carcinoma

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2018English

Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

The Prognostic Value of Niemann-Pick C1-Like Protein 1 and Niemann-Pick Disease Type C2 in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2018English

Astrocyte Elevated Gene-1 Regulates Hepatocellular Carcinoma Development and Progression

Journal of Clinical Investigation
Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy